Skip to content

SELACA: what changed

BE 0803.070.027NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€4,392
2024 · €81,284-€85,676
Equity
€77,892
2024 · €82,284-€4,392
Cash
€119,627
2024 · €74,738+€44,889
Balance sheet total
€137,899
2024 · €148,012-€10,113

Largest movements

2024 to 2025
Assets
  • Deferred charges and accrued income -€47,610

    down €47,610 (-98.2%), from €48,505 to €895

  • Cash +€44,889

    up €44,889 (+60.1%), from €74,738 to €119,627

    mainly Deferred charges and accrued income (+€47,610) and Depreciation (+€6,812)

  • Tangible fixed assets -€6,812

    down €6,812 (-28.2%), from €24,190 to €17,378

Equity and liabilities
  • Debts after one year -€6,909

    down €6,909 (-37.4%), from €18,491 to €11,582

  • Profit (loss) carried forward -€4,392

    down €4,392 (-10.9%), from €40,375 to €35,983

Income statement
  • Gross operating margin -€118,207

    down €118,207 (-96.1%), from €122,946 to €4,739

  • Taxes -€27,933

    down €27,933 (-97.2%), from €28,726 to €793

  • Depreciation -€3,088

    down €3,088 (-31.2%), from €9,900 to €6,812

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €81,284
Gross operating margin -€118,207
Depreciation +€3,088
Other operating charges +€431
Financial charges +€1,078
Taxes +€27,933
Result 2025 -€4,392
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€51,494
Investment €0
Financing -€6,606
Cash 2024 €74,738
Net result for the year -€4,392
Depreciation +€6,812
Receivables within one year +€580
Deferred charges and accrued income +€47,610
Trade debts +€121
Tax, wage and social debts +€425
Accrued charges and deferred income +€339
Debts after one year -€6,909
Current portion of long-term debt +€304
Cash 2025 €119,627
brings cash intakes cash out
Every line side by side 35 lines
Line Code 2024 2025 Change %
Total assets 20/58 €148,012 €137,899 -€10,113 -6.8%
Fixed assets 21/28 €24,190 €17,378 -€6,812 -28.2%
Tangible fixed assets 22/27 €24,190 €17,378 -€6,812 -28.2%
Furniture and vehicles 24 €24,190 €17,378 -€6,812 -28.2%
Current assets 29/58 €123,822 €120,521 -€3,301 -2.7%
Amounts receivable within one year 40/41 €580 - -€580
Other amounts receivable 41 €580 - -€580
Cash at bank and in hand 54/58 €74,738 €119,627 +€44,889 +60.1%
Deferred charges and accrued income 490/1 €48,505 €895 -€47,610 -98.2%
Total equity and liabilities 10/49 €148,012 €137,899 -€10,113 -6.8%
Equity 10/15 €82,284 €77,892 -€4,392 -5.3%
Contributions 10/11 €1,000 €1,000 = 0.0%
Reserves 13 €40,909 €40,909 = 0.0%
Distributable reserves 133 €40,909 €40,909 = 0.0%
Profit (loss) carried forward 14 €40,375 €35,983 -€4,392 -10.9%
Amounts payable 17/49 €65,728 €60,007 -€5,721 -8.7%
Amounts payable after more than one year 17 €18,491 €11,582 -€6,909 -37.4%
Financial debts 170/4 €18,491 €11,582 -€6,909 -37.4%
Amounts payable within one year 42/48 €47,237 €48,087 +€849 +1.8%
Current portion of amounts payable after more than one year 42 €6,606 €6,909 +€304 +4.6%
Trade debts 44 €1,399 €1,520 +€121 +8.7%
Suppliers 440/4 €1,399 €1,520 +€121 +8.7%
Taxes, remuneration and social security 45 €39,233 €39,657 +€425 +1.1%
Taxes 450/3 €39,233 €39,657 +€425 +1.1%
Accrued charges and deferred income 492/3 - €339 +€339
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €9,900 €6,812 -€3,088 -31.2%
Other operating charges 640/8 €846 €415 -€431 -51.0%
Gross operating margin 9900 €122,946 €4,739 -€118,207 -96.1%
Operating profit (loss) 9901 €112,200 -€2,488 -€114,687
Financial charges 65/66B €2,189 €1,111 -€1,078 -49.3%
Recurring financial charges 65 €2,189 €1,111 -€1,078 -49.3%
Profit (loss) for the period before taxes 9903 €110,011 -€3,598 -€113,609
Income taxes 67/77 €28,726 €793 -€27,933 -97.2%
Profit (loss) for the period 9904 €81,284 -€4,392 -€85,676
Profit (loss) for the period to be appropriated 9905 €81,284 -€4,392 -€85,676

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€176,253 to €231,176

Midpoint €199,138 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €77,892
Capitalised earnings €274,614 to €384,460
Indication €176,253 to €231,176

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€77,892
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€77,892

Capitalised earnings

net result for the year (9904)
2025
-€4,392
2024
€81,284
Average result
€38,446
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€274,614 / €320,383 / €384,460

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.